Harvard Bioscience Inc.

NASDAQ: HBIO · Real-Time Price · USD
0.48
-0.05 (-9.06%)
At close: Aug 11, 2025, 3:59 PM

Harvard Bioscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
21.77M 24.56M 21.97M 23.1M 24.51M 28.15M 25.36M 28.76M 29.98M 28.43M 26.92M 29.21M 28.78M 33.05M 29.66M 29.2M 26.99M
Cost of Revenue
9.59M 10.54M 9.21M 11.21M 11.07M 13.21M 10.64M 12.09M 11.63M 12.59M 14.75M 12.57M 12.6M 13.49M 13.36M 12.84M 11.56M
Gross Profit
12.18M 14.01M 12.77M 11.89M 13.44M 14.94M 14.73M 16.67M 18.35M 15.83M 12.17M 16.64M 16.18M 19.56M 16.31M 16.35M 15.43M
Operating Income
-40.08M 11K -1.87M -1.82M -1.31M 282K -933K 796K 1.75M -457K -4.31M -944K -6.71M 1.7M 548K 58K -239K
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-50.79M 590K -4.49M -3.28M -4.48M -1.1M -562K -2.1M 1.21M -892K -4.69M 3.42M -7.02M 1.13M 45K -632K -684K
Net Income
-50.34M 18K -4.8M -2.93M -4.69M -1.82M -1.24M -980K 622K -1.67M -3.4M 2.44M -6.88M 961K -170K -410K -669K
Selling & General & Admin
10.16M 10.2M 10.56M 11.08M 11.87M 11.51M 11.54M 11.53M 12.31M 11.81M 12.14M 12.57M 13.01M 13.46M 11.64M 12.13M 11.72M
Research & Development
2.32M 2.33M 2.57M 2.63M 2.88M 3.15M 2.76M 2.96M 2.9M 2.85M 2.76M 3.5M 3.22M 2.95M 2.66M 2.7M 2.49M
Other Expenses
39.78M 1.47M 1.51M n/a -142K n/a 45K -372K 1.39M 1.63M 1.57M 1.45M 78K -189K -130K -313K -34K
Operating Expenses
52.26M 14M 14.64M 13.71M 14.75M 14.66M 15.66M 15.88M 16.6M 16.29M 16.48M 17.52M 17.7M 17.86M 15.76M 16.3M 15.67M
Interest Expense
-802K 853K 856K 749K 751K 794K 882K 941K 974K 900K 749K 515K 384K 379K 373K 377K 411K
Selling & Marketing Expenses
4.97M 5.39M 5.52M 5.39M 5.9M 6.22M 5.73M 6.18M 5.98M 5.95M 5.82M 6.59M 6.69M 7.34M 6.18M 5.73M 5.39M
Cost & Expenses
61.85M 20.41M 23.84M 24.92M 25.82M 27.87M 26.3M 27.96M 28.23M 28.88M 31.23M 30.09M 30.3M 31.36M 29.11M 29.14M 27.23M
Income Tax Expense
-454K 572K 311K -353K 210K 715K 677K -1.12M 585K 774K -1.28M 986K -138K 170K 215K -222K -15K
Shares Outstanding (Basic)
44.1M 43.54M 43.61M 43.49M 43.4M 42.71M 42.69M 42.35M 42.12M 42.1M 41.64M 41.3M 40.47M 40.84M 40.75M 40.15M 39.79M
Shares Outstanding (Diluted)
44.1M 43.54M 43.61M 43.49M 43.4M 42.71M 42.69M 42.35M 42.78M 42.1M 41.64M 42.56M 41.22M 43.37M 40.75M 40.15M 39.79M
EPS (Basic)
-1.14 0.00 -0.11 -0.07 -0.11 -0.04 -0.03 -0.02 0.01 -0.04 -0.08 0.06 -0.17 0.02 -0.00 -0.01 -0.02
EPS (Diluted)
-1.14 0.00 -0.11 -0.07 -0.11 -0.04 -0.03 -0.02 0.01 -0.04 -0.08 0.06 -0.17 0.02 -0.00 -0.01 -0.02
EBITDA
-40.08M 3.16M -1.87M -773K -2.28M 1.46M 846K 564K 3.47M 3.48M -2M 948K -4.79M 3.94M 2.53M 1.66M 1.64M
EBIT
n/a 1.44M -3.63M -2.53M -3.73M -309K 320K 796K 1.75M 8K -3.94M -882K -6.63M 2.02M 648K -255K -273K
Depreciation & Amortization
n/a 1.76M 1.81M 1.76M 1.74M 1.77M 1.78M 1.72M 1.72M 1.96M 1.94M 1.83M 1.85M 1.92M 1.88M 1.91M 1.91M